Harini Sarva, Ariel Antezana, Johanne Policard, Diana Rojas-Soto, Yassir El-Sherif, Ilya Kister, Steven Pulitzer and Yaacov Anziska
Neuromyelitis Optica (NMO) is a potentially devastating, complex autoimmune disease of the central nervous
system that differs clinically and pathologically from the more common Multiple Sclerosis (MS). In this paper, we
briefly describe our clinical experience with NMO patients treated in an inner city hospital in central Brooklyn, New
York, and offer a an up-to-date discussion of diagnosis, treatment, and prognosis of this rare condition.
